CDKN2A/CDK4 molecular study on 155 Italian subjects with familial and/or primary multiple melanoma

Pigment Cell and Melanoma Research

Volumn 21, Issue 2, 2008, Pages 209-211

  Majore, S ^a   De Simone, P ^b   Crisi, A ^a   Eibenschutz, L ^b   Binni, F ^a   Antigoni, I ^a   De Bernardo, C ^a   Catricala C ^b   Grammatico, P ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

FAMILIAL DISEASE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; ITALY; LETTER; MELANOMA; PREVALENCE;

ADULT; AGED; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; MALE; MELANOMA; MIDDLE AGED; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; PREVALENCE; SKIN NEOPLASMS;

EID: 42249098884     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2008.00446.x     Document Type: Letter

References (8)

1. Goldstein, A.M., Chidambaram, A., Halpern, A., Holly, E.A., Guerry, I.V.D., Sagebiel, R., Elder, D.E. Tucker, M.A. (2002). Rarity of CDK4 germline mutations in familial melanoma. Melanoma Res. 12, 51 55.
2. Goldstein, A.M., Chan, M., Harland, M. et al. (2006). High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res. 15, 66.
3. Mantelli, M., Barile, M., Ciotti, P. et al. (2002). High prevalence of the G101W germline mutation in the CDKN2A (P16ink4a) gene in 62 Italian malignant melanoma families. Am. J. Med. Genet. 107, 212 221.
4. Molven, A., Grimstvedt, M.B., Steine, S.J., Harland, M., Avril, M.F., Hayward, N.K. Akslen, L.A. (2005). A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes Chromosomes Cancer 44, 10 18.
5. Newton Bishop, J.A., Harland, M., Bennett, D.C., Bataille, V., Goldstein, A.M., Tucker, M.A., Ponder, B.A., Cuzick, J., Selby, P. Bishop, D.T. (1999). Mutation testing in melanoma families: INK4A, CDK4 and INK4D. Br. J. Cancer 80, 295 300.
6. Soufir, N., Avril, M.F., Chompret, A., Demenais, F., Bombled, J., Spatz, A., Stoppa-Lyonnet, D., Bénard, J. Bressac-de Paillerets, B. (1998). Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. Hum. Mol. Genet. 7, 209 216.
7. Soufir, N., Ollivaud, L., Bertrand, G. et al. (2007). French CDK4-positive melanoma family with a co-inherited EDNRB mutation. J. Dermatol. Sci. 46, 61 64.
8. Zuo, L., Weger, J., Yang, Q., Goldstein, A.M., Tucker, M.A., Walker, G.J., Hayward, N. Dracopoli, N.C. (1996). Germline mutations in the p16ink4a binding domain of CDK4 in familial melanoma. Nat. Genet. 12, 97 99.